Schmid M, Malicki D, Nobori T, Rosenbach M D, Campbell K, Carson D A, Carrera C J
Stein Institute for Research on Aging, University of California, San Diego, La Jolla 92093, USA.
Oncogene. 1998 Nov 19;17(20):2669-75. doi: 10.1038/sj.onc.1202205.
Homozygous deletions of the tumor suppressor gene p16INK4A and deficiency of methylthioadenosine phosphorylase (MTAP), both located on chromosome 9p21, have been independently reported in non-small cell lung cancer (NSCLC). To determine the frequency of co-deletion of these two genes, we investigated 50 samples of primary NSCLC using a quantitative PCR-ELISA. All specimens were fixed in formalin, paraffin embedded and stored until assayed. Histologic subtypes included 25 adenocarcinomas (50%), 21 squamous cell carcinomas (42%) and four large cell carcinomas (8%). Homozygous deletions of MTAP exon 8 could be detected in 19 of 50 NSCLC samples (38%). Adenocarcinoma (11 of 25, 44%) showed a higher deletion frequency than squamous cell carcinoma (six of 21, 29%). In contrast, homozygous p16INK4A deletions were detected in only nine of 50 (18%) samples using specific primers for p16INK4A exon 1alpha. No difference between the histological subtypes and p16INK4A deletion frequency was observed. We further investigated the ten samples with MTAP deletions but intact p16INK4A exon 1alpha with primers specific for p16INK4A exon 3, the exon nearest to MTAP exon 8. Interestingly, none of the ten samples had deletion of the p16INK4A exon 3 coding region. Fine mapping analysis performed in ten samples showed a frequent breakpoint between MTAP exon 4 and exon 5. In addition, p16 protein expression could not be detected in five out of six samples with intact p16 but deleted MTAP locus. These data show a high frequency of homozygous MTAP deletions in NSCLC which is associated with detectable co-deletion of p16INK4A in only half of the cases. This result suggests the existence either of another tumor suppressor gene telomeric of p16INK4A or of deletions involving 3'-untranslated (3'-UTR) regulatory regions of p16INK4A that can interfere with its expression or function.
抑癌基因p16INK4A的纯合缺失以及甲硫腺苷磷酸化酶(MTAP)的缺陷,二者均位于9号染色体p21区域,此前在非小细胞肺癌(NSCLC)中均有独立报道。为了确定这两个基因共缺失的频率,我们使用定量PCR-ELISA法对50例原发性NSCLC样本进行了研究。所有标本均用福尔马林固定,石蜡包埋并保存至检测。组织学亚型包括25例腺癌(50%)、21例鳞状细胞癌(42%)和4例大细胞癌(8%)。在50例NSCLC样本中的19例(38%)可检测到MTAP外显子8的纯合缺失。腺癌(25例中的11例,44%)的缺失频率高于鳞状细胞癌(21例中的6例,29%)。相比之下,使用针对p16INK4A外显子1α的特异性引物,在50例样本中仅9例(18%)检测到p16INK4A的纯合缺失。未观察到组织学亚型与p16INK4A缺失频率之间存在差异。我们进一步使用针对p16INK4A外显子3(最靠近MTAP外显子8的外显子)的引物,对10例MTAP缺失但p16INK4A外显子1α完整的样本进行了研究。有趣的是,这10例样本中无一例p16INK4A外显子3编码区缺失。对10例样本进行的精细定位分析显示,MTAP外显子4和外显子5之间频繁出现断点。此外,在6例p16完整但MTAP基因座缺失的样本中,有5例检测不到p16蛋白表达。这些数据表明,NSCLC中MTAP纯合缺失的频率很高,且仅在半数病例中与可检测到的p16INK4A共缺失相关。这一结果提示,要么存在位于p16INK4A端粒侧的另一个抑癌基因,要么存在涉及p16INK4A 3'-非翻译(3'-UTR)调控区的缺失,从而可能干扰其表达或功能。